2026-09-19T07:25:00Zhttps://dspace.mit.edu/server/oai/requestoai:dspace.mit.edu:1721.1/906772026-06-17T14:46:37Zcom_1721.1_7582com_1721.1_7581col_1721.1_131022
Alan P. Jasanoff.
Matsumoto, Yuri, Ph. D. Massachusetts Institute of Technology
Massachusetts Institute of Technology. Department of Biological Engineering.
Massachusetts Institute of Technology. Department of Biological Engineering
2014-10-08T15:22:09Z
2014-10-08T15:22:09Z
2014
2014
http://hdl.handle.net/1721.1/90677
890465963
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Biological Engineering, 2014.
Cataloged from PDF version of thesis.
Includes bibliographical references (pages 129-150).
Magnetic resonance imaging (MRI) is gaining recognition as a powerful tool in biological research, offering non-invasive access to anatomy and activity at high spatial and temporal resolution. However, the range of biological phenomena accessible to measurement by MRI is limited, due to a current lack of molecular-level methods for detecting physiological processes in living organisms. One way to overcome this limitation is to develop contrast agents that report physiological events at a molecular level. Traditionally MRI contrast agents have been based on small molecules that chelate paramagnetic ions such as Gd (III), but synthesis and delivery of such exogenously applied agents are complicated. Genetically-encodable MRI sensors may overcome some of these issues. In this thesis, we describe new class of MRI contrast agents which will be broadly applicable as genetically-controlled tools for in vivo imaging. The major goal of my thesis research was to improve the sensitivity of the existing protein-based MRI contrast agent, ferritin (Ft) by inducing it to accumulate larger number of iron atoms per particle in a physiological environment. Using a high throughput genetic screening process, we obtained Ft mutants that show threefold greater cellular iron accumulation than mammalian heavy chain Ft. In another project, we used the engineered Ft to develop a dynamic gene reporter that responds to changes in gene expression levels in vivo via aggregation-dependent MRI contrast changes. Successful creation of genetically-encodable MRI contrast agents that are robust and sensitive enough to be applied in vivo will enable neuroscientists and biologists to study molecular processes of living subjects.
by Yuri Matsumoto.
Ph.D.
150 pages
eng
Massachusetts Institute of Technology
MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission.
http://dspace.mit.edu/handle/1721.1/7582
Biological Engineering.
Engineering genetically-encodable MRI contrast agents for in vivo imaging
Engineering genetically-encodable magnetic resonance imaging contrast agents for in vivo imaging
Thesis
application/pdf
false
Publication
unknown
unknown
<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="c2f2a7a4-579c-4b1b-846a-019a61a0e257">
<Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type>
<Language>eng</Language>
<Title>Engineering genetically-encodable MRI contrast agents for in vivo imaging</Title>
<Subtitle>Engineering genetically-encodable magnetic resonance imaging contrast agents for in vivo imaging</Subtitle>
<PublishedIn>
<Publication>
</Publication>
</PublishedIn>
<PublicationDate>2014</PublicationDate>
<Authors>
<Author>
<DisplayName>Matsumoto, Yuri, Ph. D. Massachusetts Institute of Technology</DisplayName>
<Affiliation>
<OrgUnit>
</OrgUnit>
</Affiliation>
</Author>
</Authors>
<Editors>
</Editors>
<Publishers>
<Publisher>
<DisplayName>Massachusetts Institute of Technology</DisplayName>
<OrgUnit />
</Publisher>
</Publishers>
<License>http://dspace.mit.edu/handle/1721.1/7582</License>
<Keyword>Biological Engineering.</Keyword>
<Abstract>Magnetic resonance imaging (MRI) is gaining recognition as a powerful tool in biological research, offering non-invasive access to anatomy and activity at high spatial and temporal resolution. However, the range of biological phenomena accessible to measurement by MRI is limited, due to a current lack of molecular-level methods for detecting physiological processes in living organisms. One way to overcome this limitation is to develop contrast agents that report physiological events at a molecular level. Traditionally MRI contrast agents have been based on small molecules that chelate paramagnetic ions such as Gd (III), but synthesis and delivery of such exogenously applied agents are complicated. Genetically-encodable MRI sensors may overcome some of these issues. In this thesis, we describe new class of MRI contrast agents which will be broadly applicable as genetically-controlled tools for in vivo imaging. The major goal of my thesis research was to improve the sensitivity of the existing protein-based MRI contrast agent, ferritin (Ft) by inducing it to accumulate larger number of iron atoms per particle in a physiological environment. Using a high throughput genetic screening process, we obtained Ft mutants that show threefold greater cellular iron accumulation than mammalian heavy chain Ft. In another project, we used the engineered Ft to develop a dynamic gene reporter that responds to changes in gene expression levels in vivo via aggregation-dependent MRI contrast changes. Successful creation of genetically-encodable MRI contrast agents that are robust and sensitive enough to be applied in vivo will enable neuroscientists and biologists to study molecular processes of living subjects.</Abstract>
<Access xmlns="http://purl.org/coar/access_right"
>
</Access>
</Publication>